Table 2 Common treatment-related adverse events (> 1% of patients) of grade ≥ 3 classified by System Organ Class and Preferred Term, (n = 113)
No. (%) | |
|---|---|
General disorders and alterations related to the administration site | |
Asthenia | 6 (5.3) |
Hematological disorders | |
Neutropenia | 21 (18.6) |
Febrile neutropenia | 5 (4.4) |
Thrombocytopenia | 5 (4.4) |
Anemia | 2 (1.8) |
Hemato-toxicity | 2 (1.8) |
Gastrointestinal disorders | |
Diarrhea | 3 (2.7) |
Nervous system disorders | |
Neurotoxicity | 2 (1.8) |